Evaluation of Eslicarbazepine-loaded reduced Graphene oxide Polymeric nanoparticles by Pentylenetetrazole (PTZ) induced convulsion in mice

Reddy Madhavi; Dr. Pabba Parameshwar

Evaluation of Eslicarbazepine-loaded reduced Graphene oxide Polymeric nanoparticles by Pentylenetetrazole (PTZ) induced convulsion in mice

Authors: Reddy Madhavi, Dr. Pabba Parameshwar

Unique Paper ID: 166465
Volume: 8
Issue: 8
PageNo: 645-650

Keywords: Eslicarbazepine Polymeric Nanoparticles Epilepsy Drug Delivery In-vivo Release Nanotechnology.

Abstract:
Millions of people worldwide suffer greatly from epilepsy, a chronic neurological illness that severely lowers quality of life. Typical antiepileptic medications frequently have negative side effects, low absorption, and inadequate patient compliance. The objective of this research is to devise and evaluate polymeric nanoparticles loaded with escicarbazepine to improve the treatment of epilepsy. A new antiepileptic medication called eslicarbazepine acetate has encouraging therapeutic potential, however its physicochemical characteristics limit its clinical usefulness. In this paper, we investigated polymeric nanoparticles loaded with Eslicarbazepine using biocompatible and biodegradable polymers. They are put through in-vivo release experiments to look at the kinetics of eslicarbazepine's release from the polymeric nanoparticles. To ascertain the drug release mechanisms and guarantee a prolonged and regulated release, the release profiles were examined. The outcomes showed that the polymeric nanoparticles offered Eslicarbazepine a stable and effective delivery mechanism, increasing its bioavailability and therapeutic efficiency. According to our research, polymeric nanoparticles loaded with Eslicarbazepine may be able to minimize adverse effects and lower the frequency of doses, which would increase patient compliance and treatment results overall. This study demonstrates how medication delivery systems based on nanotechnology may transform the way epilepsy is treated and lays the groundwork for future in vivo research and clinical use.

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 8
Issue: 8
PageNo: 645-650

Evaluation of Eslicarbazepine-loaded reduced Graphene oxide Polymeric nanoparticles by Pentylenetetrazole (PTZ) induced convulsion in mice

Available:https://ijirt.org/Article?manuscript=166465

22 Aug, 2024

DESIGN OF ANN AND ANFIS CONTROLLER BASED UPFC EMBEDDED WITH THREE LEVEL CASCADED H BRIDGE INVERTER WITH SPWM TECHNIQUE FOR FAST RESTORATION OF POWER FOLLOWING SEVERE TRANSIENT CONDITIONS ON TRANSMISSION LINES

21 Aug, 2024

ANALYZING THE IMPACT OF ARTIFICIAL INTELLIGENCE ON HUMAN RESOURCE MANAGEMENT

20 Aug, 2024

INTERNATIONAL MARKETING UNVEILED: KEY FACTORS, INDIAN STANDARDS, COMPARATIVE STRATEGIES, AND PATHWAYS TO GLOBAL SUCCESS

16 Aug, 2024

ANALYSIS ON THE ECONOMIC BENEFITS OF SUSTAINABLE PRACTICES IN ENHANCING WEALTH CREATION AND EQUITABLE RESOURCE DISTRIBUTION

15 Aug, 2024

INTEGRATED MANAGEMENT STRATEGIES FOR ALTERNARIA BLIGHT IN MUSTARD: A COMPREHENSIVE REVIEW

13 Aug, 2024

AGILE HR PRACTICES: ADAPTING THE STRATEGIES & RAPIDLY CHANGING BUSSINESS ENVIRONMENT

10 Aug, 2024

IMPACT OF MOBILE BANKING ON EXPANSION OF BANKING SERVICES

07 Aug, 2024

PREDICTIVE MODEL-BASED SELECTION OF DEEP NEURAL NETWORKS FOR EMBEDDED IMAGE CLASSIFICATION

31 Jul, 2024

OPTIMAL CAPITAL STRUCTURE DETERMINATION: ASSESSING THE IMPACT ON FINANCIAL PERFORMANCE OF BSE LISTED COMPANIES ACROSS IGAAP AND IND AS PERIODS

31 Jul, 2024

INTEGRATED MANAGEMENT STRATEGIES FOR ALTERNARIA BLIGHT IN MUSTARD: A COMPREHENSIVE REVIEW

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry